tiprankstipranks
Alliance Pharma PLC (GB:APH)
LSE:APH
UK Market

Alliance Pharma (APH) Income Statement

Compare
52 Followers

Alliance Pharma Income Statement

Last quarter (Q2 2024), Alliance Pharma's total revenue was £83.86M, an increase of 6.47% from the same quarter last year. In Q2, Alliance Pharma's net income was £4.66M. See Alliance Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
£ 180.68M£ 167.42M£ 163.21M£ 129.80M£ 135.64M
Gross Profit
£ 105.02M£ 101.68M£ 109.45M£ 82.82M£ 86.08M
Operating Expenses
£ 143.46M£ 72.88M£ 81.72M£ 54.44M£ 48.63M
Depreciation and Amortization
£ 10.33M£ 10.76M£ 10.11M£ 8.91M£ 1.68M
EBITDA
£ -28.94M£ -6.86M£ 31.91M£ 24.58M£ 36.53M
Operating Income
£ -38.44M£ 10.57M£ 21.57M£ 27.15M£ 35.63M
Other Income/Expenses
£ -10.36M£ -33.62M£ -3.42M£ -3.30M£ -4.55M
Pretax Income
£ -48.80M£ 5.21M£ 18.16M£ 13.02M£ 31.08M
Net Income
£ -33.14M£ 936.00K£ 7.32M£ 8.03M£ 25.01M
Per Share Metrics
£ ―£ ―£ ―£ ―£ ―
Basic EPS
£ -0.06£ 0.00£ 0.01£ 0.02£ 0.05
Diluted EPS
£ -0.06£ 0.00£ 0.01£ 0.01£ 0.05
Weighted Average Shares Outstanding
540.14M 539.48M 535.30M 531.06M 520.69M
Weighted Average Shares Outstanding (Diluted)
540.14M 545.28M 542.33M 537.32M 530.16M
Currency in GBP

Alliance Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis